Correction: Novel Pyrrolo[3,2-d]Pyrimidine Compounds Target Mitochondrial and Cytosolic One-Carbon Metabolism with Broad-spectrum Antitumor Efficacy.

Dekhne, Aamod S; Shah, Khushbu; Ducker, Gregory S; Katinas, Jade M; Wong-Roushar, Jennifer; Nayeen, Md Junayed; Doshi, Arpit; Ning, Changwen; Bao, Xun; Frühauf, Josephine; Liu, Jenney; Wallace-Povirk, Adrianne; O'Connor, Carrie; Dzinic, Sijana H; White, Kathryn; Kushner, Juiwanna; Kim, Seongho; Hüttemann, Maik; Polin, Lisa; Rabinowitz, Joshua D; Li, Jing; Hou, Zhanjun; Dann, Charles E; Gangjee, Aleem; Matherly, Larry H

Dekhne, Aamod S; Shah, Khushbu; Ducker, Gregory S; Katinas, Jade M; Wong-Roushar, Jennifer; Nayeen, Md Junayed; Doshi, Arpit; Ning, Changwen; Bao, Xun; Frühauf, Josephine; Liu, Jenney; Wallace-Povirk, Adrianne; O'Connor, Carrie; Dzinic, Sijana H; White, Kathryn; Kushner, Juiwanna; Kim, Seongho; Hüttemann, Maik; Polin, Lisa; Rabinowitz, Joshua D; Li, Jing; Hou, Zhanjun; Dann, Charles E; Gangjee, Aleem; Matherly, Larry H.

Mol Cancer Ther ; 22(2): 287, 2023 Feb 01.

Article in En | MEDLINE | ID: mdl-36602953

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2023 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google